HIV variants and hepatitis B surface antigen mutants: Diagnostic challenges for immunoassays

Journal of Medical Virology

Volumn 78, Issue SUPPL. 1, 2006, Pages

  Schochetman, Gerald ^a,b   Kuhns, Mary C ^a  

^a ABBOTT DIAGNOSTICS   (United States)

^b ABBOTT LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN;

EDITORIAL; HEPATITIS B; HEPATITIS B VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOASSAY; VIRUS INFECTION; VIRUS MUTANT; VIRUS RECOMBINATION; VIRUS STRAIN;

FALSE NEGATIVE REACTIONS; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOASSAY; MUTATION; SENTINEL SURVEILLANCE; VARIATION (GENETICS);

EID: 33745588854     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.20598     Document Type: Editorial

References (15)

1. Barin F, Plantier J-C, Brand D, et al. 2006. Human immunodeficiency virus serotyping on dried serum spots as a screening tool for the surveillance of the AIDS epidemic. J Med Virol 78(Suppl 1): S13-S18.
2. Bartholomeusz A, Locarnini S. 2006. Hepatitis B virus mutations associated with antiviral therapy. J Med Virol 78(Suppl 1):S52-S55.
3. Bennett D. 2005. HIV-1 genetic diversity surveillance in the United States. JID 192:4-9.
4. Brennan C, Bodelle P, Coffey R, Harris B, Holzmayer V, Luk K-C, Swanson P, Yamaguchi J, Vallari A, Devare SG, Schochetman G, Hackett Jr., J. 2006. HIV global surveillance: Foundation for retroviral discovery and assay development. J Med Virol 78(Suppl 1): S24-S29.
5. Cartwright CP. 2006. The changing epidemiology of HIV/AIDS at a Minnesota hospital: Impact of demographic change and viral diversity. J Med Virol 78(Suppl 1):S19-S21.
6. Coleman PF. 2006. Surveillance for hepatitis B surface antigen mutants. J Med Virol 78(Suppl 1):S56-S58.
7. Delwart E, Kuhns MC, Busch MP. 2006. Surveillance of the genetic variation in incident HIV, HCV, and HBV infections in blood and plasma donors: Implications for blood safety, diagnostics, treatment, and molecular epidemiology. J Med Virol 78(Suppl 1):S30-S35.
8. Echevarria JM, Avellon A. 2006. Hepatitis B virus genetic diversity. J Med Virol 78(Suppl 1):S36-S42.
9. Gerlich W. 2004. Diagnostic problems caused by HBsAg mutants: A consensus report of an expert meeting. Intervirol 47:310-313.
10. Lee S, Hu J, Tang S, Wood O, Francis K, Machuca A, Rios M, Daniel S, Vockley C, Awazhi B, Zekeng L, Hewlett I. 2006. Evaluation of FDA licensed assays using plasma from Cameroonian blood donors. J Med Virol 78(Suppl 1):S22-S23.
11. McCutchan FE. 2006. Global epidemiology of HIV. J Med Virol 78(Suppl 1):S7-S12.
12. Osiowy C. 2006. Detection of HBsAg mutants. J Med Virol 78(Suppl 1): S48-S51.
13. Scheiblauer H, Soboll H, Nick S. 2006. Evaluation of 17 CE-marked HBsAg assays with respect to clinical sensitivity, analytical sensitivity, and hepatitis B virus mutant detection. J Med Virol 78(Suppl 1):S66-S70.
14. Tabor E. 2006. Infections by hepatitis B surface antigen gene mutants in Europe and North America. J Med Virol 78(Suppl 1):S43-S47.
15. Weber B. 2006. Diagnostic impact of the genetic variability of the hepatitis B virus surface antigen gene. J Med Virol 78(Suppl 1): S59-S65.